Publications by authors named "Jose Luis Barranco-Quintana"
Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorisations to January 2024.
Expert Rev Vaccines
September 2024
Article Synopsis
- Recent years have seen a rise in the approval of monoclonal antibodies (mAbs) and other biological treatments, each with varied immunosuppressive effects and mechanisms that necessitate personalized vaccination schedules for patients.
- Current vaccine recommendations for patients on mAbs are mainly based on expert opinions rather than individualized protocols, highlighting a significant gap in research addressing the diverse uses of these treatments.
- This review aims to compile information on mAbs approved by the EMA as of January 1, 2024, and provide a practical guide for personalizing vaccination strategies for immunocompromised individuals, reflecting recent developments in vaccine technology and administration practices.
Introduction: Monoclonal antibodies (mAbs) have become an increasing source of biological treatments. Clinicians should make an effort to update their knowledge on mechanisms of action, indications, and adverse events of these novel therapies. Most of them have immunosuppressive effects and, therefore, vaccination is indicated.
View Article and Find Full Text PDFPurpose: To evaluate the risk of PD associated with tea consumption.
Material And Methods: We reviewed all observational studies that evaluated the association between PD risk and tea consumption. Only, 12 studies were identified: 11 case-control and 1 cohort.
Purpose: To estimate the pooled risk of coffee consumption for Alzheimer's disease (AD).
Material And Methods: We have reviewed all observational studies that evaluated the association between AD risk and coffee consumption. Four studies were identified: two case-control studies and two cohorts.
Objective: The accumulation of risk factors in hospitalized patients is one of the elements contributing to the increase in the frequency of nosocomial infection in the intensive care unit (ICU). Our aim was to identify nosocomial infection risk factors in the ICU of our hospital.
Methods: We performed a prospective cohort study of 1,134 patients admitted to the ICU for at least 24 hours in 2001.